Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Fondazione Italiana Linfomi - ETS
City of Hope Medical Center
University of Nebraska
University of Nebraska
Universität des Saarlandes
Ruijin Hospital
University of Miami
M.D. Anderson Cancer Center
Northwestern University